文献速递功能神经外科

苍白球与丘脑底核刺激治疗颅颈肌张力障碍的4年随访比较

Comparison of Pallidal and Subthalamic Stimulation for Cranial Cervical Dystonia: A 4-Year Follow-up Study.
PubMed 文献 · Neurosurgery · 2025-10-09

这项单中心回顾性研究分析了78例颅颈肌张力障碍患者,分为GPi-DBS组(38例)和STN-DBS组(40例),随访4年。STN组在6个月时运动症状改善优于GPi组,但多重比较校正后差异不显著;两组长期疗效相当,均改善情绪和生活质量,认知稳定。病程与运动改善呈负相关,早期干预重要。

要点

  • GPi-DBS与STN-DBS均可有效改善颅颈肌张力障碍的运动症状和生活质量,长期疗效相当。
  • STN组6个月运动改善优于GPi组,但多重比较校正后不显著。
  • 病程与长期运动改善负相关,早期干预是关键。

核心结论

  • GPi-DBS和STN-DBS均能有效改善颅颈肌张力障碍患者的运动症状和生活质量,长期疗效相当。
  • 早期干预至关重要,病程是长期运动改善的重要预后因素。

研究设计与样本

  • 回顾性研究,纳入单中心连续78例颅颈肌张力障碍患者,接受双侧DBS治疗。
  • 非随机分为两组:GPi-DBS组38例,STN-DBS组40例。
  • 在基线、术后6个月及1、2、3、4年使用标准化量表评估运动和非运动症状。
  • 采用多重线性回归和逻辑回归分析长期预后的潜在因素。

主要发现

  • 后续随访点两组运动症状改善无显著差异。
  • STN组在6个月、2年、3年、4年的Burke-Fahn-Marsden肌张力障碍评定量表运动子量表眼部评分改善更大,但多重比较校正后差异不显著。
  • 末次随访时两组情绪和生活质量均显著改善,认知功能保持稳定。

临床怎么用

  • 对于颅颈肌张力障碍,GPi-DBS和STN-DBS均可作为有效治疗选择,长期疗效相当。
  • 应尽早考虑DBS干预,因病程较短与更好的长期运动改善相关。

局限性

  • 回顾性研究设计,非随机分组,可能存在选择偏倚。
  • 单中心研究,样本量有限(78例),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Deep brain stimulation (DBS) targeting the globus pallidus internus (GPi) or subthalamic nucleus (STN) is well established for treatment of craniocervical dystonia (CCD). This study aims to compare the long-term outcomes of GPi-DBS and STN-DBS for CCD and identify potential prognostic factors. METHODS: This retrospective study analyzed 78 consecutive patients with CCD treated with bilateral DBS at a single medical center, comprising 2 nonrandomized cohorts: GPi-DBS (n = 38) and STN-DBS (n = 40). Motor and nonmotor symptoms were assessed using standardized rating scales at baseline, 6 months, and 1, 2, 3, and 4 years after surgery. Multiple linear and logistic regression analyses were performed to identify potential prognostic factors for long-term outcomes. RESULTS: At 6 months, the STN group showed greater improvement in motor symptoms compared with the GPi group (50.48% [95% CI, 40.12%-60.84%] vs 34.92% [95% CI, 24.84%-45.00%], P = .046), although this difference was not significant after adjusting for multiple comparisons (threshold P < .01). No significant differences in motor symptom improvement were observed between the 2 groups at later follow-up points. Among all Burke-Fahn-Marsden dystonia rating scale movement subscale scores, the STN group showed greater improvement in the eye subscore at 6 months, 2 years, 3 years, and 4 years, but these differences were also not significant after adjusting for multiple comparisons. Both groups demonstrated significant improvements in mood and quality of life at the last follow-up. Cognitive functions remained stable. Multiple regression analysis revealed a negative correlation between disease duration and motor improvement (standardized β = -.023, 95% CI, -0.044% to -0.003%, P = .028). CONCLUSION: Both GPi- and STN-DBS can effectively improve motor symptoms and quality of life of patients with CCD, with comparable long-term efficacy. Early intervention is critical, with disease duration being an important prognostic factor for long-term motor improvement.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Huang J, Xie H, Jiang Y, et al. Comparison of Pallidal and Subthalamic Stimulation for Cranial Cervical Dystonia: A 4-Year Follow-up Study. Neurosurgery. 2025. PMID: 41065393. doi:10.1227/neu.0000000000003783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。